Provider review
OlleveCare review
A small video practice that may prescribe a GLP-1, with nothing priced.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
No price published; visit fee shown at booking
Visit OlleveCareThirteen states, a visit fee shown only at booking, and no word on where the medication comes from.
Price as published
OlleveCare
No price published; visit fee shown at booking
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
OlleveCare is a small virtual practice rather than a GLP-1 storefront. A provider sees you by video, may prescribe semaglutide or tirzepatide, and gives guidance on nutrition and activity, with labs only when needed; the prescription can go to your own pharmacy. That last point could be useful if you have coverage or want to shop the drug price. Beyond that there is little to go on. No price is shown for the visit or the medication, the site does not say whether the drug is compounded or branded or who supplies it, and there are no terms of service or refund policy, only a fee for very late cancellations. It serves 13 states, listed by name. The site's stats block and testimonials look unfinished, and no company name or address is printed. Nothing is sold as a low dose. If you are in one of its states and want a video visit with a prescriber, it is an option; ask about every cost before you book.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a video visit and a prescription sent to your own pharmacy
- You live in one of its 13 states
- You want lifestyle guidance alongside the prescription
Look elsewhere if
- You want to see a price before booking
- You want written terms and a named company
- You want a product sold as a low dose
What it actually costs
Price as published
No price published; visit fee shown at booking
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. A virtual practice that may prescribe semaglutide or tirzepatide after a video visit, with no price for either and no low-dose product; a smaller dose would be the prescriber's decision.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Confirm any separate fee
- Dietitian
- Not confirmed
- Labs
- Optional
- Pricing
- Check plan terms
What it does well
- Video visits with a provider, with guidance on nutrition and activity
- Prescriptions can go to your local or preferred pharmacy
- The states served are listed by name
- Labs are ordered only when a provider asks for them
- A phone number and support email are published
Pharmacy, labs and oversight
OlleveCare does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. Confirm whether clinician visits cost extra.
Transparency check
1 of 4 published openly
What OlleveCare publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
OlleveCare is a small virtual practice offering weight loss, urgent care and medication refills by video visit. Its weight-loss program may include FDA-approved or off-label medication such as semaglutide or tirzepatide, alongside guidance on nutrition, activity and lifestyle, and baseline labs when a provider asks for them. It does not say whether the medication is compounded or branded, or whether it supplies the drug or sends the prescription to your local pharmacy, which it says it can do. It lists 13 states served, including Washington, D.C. There is no terms page, no refund policy beyond a late-cancellation fee, and no company name or address. Nothing describes a low-dose program.
The honest cons
No price is published for the visit or the medication, so the cost is unknown until you book
- It does not say whether the medication is compounded or branded, or who supplies it
- Only 13 states are served
- No terms of service, refund policy, company name or address
- Its stats block and testimonials read like placeholders
- Intentional microdosing of a GLP-1 is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
OlleveCare is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way OlleveCare does. Both are partners: we may earn a commission if you start care through these links.
Partner
Direct Meds
From $249/mo sublingual · $297/mo injection
Standard plan, self-directed low dose
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Where this sits
#448 of 548
Ordered with the companies that pay us first, and OlleveCare is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Low dose vs full dose
- Is compounded GLP-1 safe?
- The true annual cost of a plan
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.